TrademarkDir
IMMUNOTHERAPY IN ONCOLOGY
LIVE

Serial Number

97154897

Owner

The Lynx Group, LLC

Attorney

Brian L. Petrequin, Esq.

Filing Date

Dec 3, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMMUNOTHERAPY IN ONCOLOGY Trademark

Serial Number: 97154897 • Registration: 7281228

IMMUNOTHERAPY IN ONCOLOGY is a trademark filed by The Lynx Group, LLC on December 3, 2021. The trademark is classified under Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

The Lynx Group, LLC

2050 Cabot Boulevard West, Suite 110
Langhorne, PA 19047

Entity Type: 16

Trademark Details

Filing Date

December 3, 2021

Registration Date

January 16, 2024

First Use in Commerce

June 1, 2023

Goods & Services

Printed publications, namely, peer-reviewed medical magazines, journals, newsletters, feature reports, monographs, and printed supplements to the foregoing in the fields of immunology, hematology, oncology and cancer

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 22, 2024 NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2024 NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jan 16, 2024 R.SR
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Aug 2, 2023 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Aug 1, 2023 CNTA
USE AMENDMENT ACCEPTED
Aug 1, 2023 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 24, 2023 ERFR
AMENDMENT TO USE PROCESSING COMPLETE
Jul 24, 2023 AUPC
USE AMENDMENT FILED
Jul 24, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jul 22, 2023 EAAU
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 21, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 21, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 24, 2023 GNFN
FINAL REFUSAL E-MAILED
Jan 24, 2023 GNFR
FINAL REFUSAL WRITTEN
Jan 24, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2021 NWOS
NEW APPLICATION ENTERED
Dec 7, 2021 NWAP

Related Trademarks

More from this Owner

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA